Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. <em>Cells</em> 2021, <em>10</em>, 670

by Ji Woong Kim, Yea Bin Cho, Sukmook Lee
Published 2021-05-01

Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy

by Ji Woong Kim, Yea Bin Cho, Sukmook Lee
Published 2021-03-01

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth

by Mee Hyun Jeoung, Taek-Keun Kim, Ji Woong Kim, Yea Bin Cho, Hee Jun Na, Byong Chul Yoo, Hyunbo Shim, Dong-Keun Song, Kyun Heo, Sukmook Lee
Published 2019-11-01